【レポートの概要(一部)】
1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 9
1.2 List of Figures 10
2 Introduction 11
2.1 Catalyst 11
2.2 Related Reports 12
2.3 About PharmaSphere Report Series 13
3 A Changing and Challenging Deal Making Landscape 14
3.1 Overview 14
3.2 Deal Drivers 15
3.2.1 The Patent Cliff 15
3.2.2 Deal-Adverse Environment 18
3.2.3 Spike in Regulatory Approvals but Innovation Gap Continues 22
3.2.4 FDA’s Proposal to Lower Regulatory Standards in Early-Stage Alzheimer’s Research 23
3.2.5 More Stringent Regulatory Regime in a Post-Vioxx and Avandia World 24
3.2.6 Viewpoint: Vioxx and Avandia Cases 25
4 An Unsustainable R&D Paradigm 27
4.1 Big Pharma’s Embrace of Disruptive Innovation May Fix Broken R&D Model 28
4.1.1 Pre-Competitive Information Sharing 28
4.1.2 Open-Source Patient Data 29
4.1.3 ‘Big Data’ and Drug Discovery 30
4.1.4 Tech Transfer in Action: Astellas Pharma Taps IT for Drug Discovery 31
4.1.5 Drug Recycling 31
4.1.6 Viewpoint: Drug Repurposing at NCATS 32
4.1.7 Tech Transfer in Action: Roche & Broad Join to Bring Failed Drugs Back from the Dead 33
5 Major Global Technology Transfer Alliances 34
5.1 The Bayh-Dole Act of 1980 34
5.2 Deals Overview 36
5.3 Biscayne Pharma Enters into Licensing Agreement with University of Miami for Growth Hormone-Releasing Technology 40
5.3.1 Deal Summary 40
5.3.2 Deal Analysis 40
5.4 Genoa Pharma Enters into Research Agreement with McMaster University for IPF 42
5.4.1 Deal Summary 42
5.4.2 Deal Analysis 42
5.5 AstraZeneca Partners with Vanderbilt University for Neuroscience Drug Discovery 44
5.5.1 Deal Summary 44
5.5.2 Deal Analysis 44
5.6 Trovagene Grants License for NPM1 Marker for AML to Duke University 45
5.6.1 Deal Summary 45
5.6.2 Deal Analysis 45
5.7 Synthetic Biologics and University of Texas Ink Research Deal to Fight Pertussis 47
5.7.1 Deal Summary 47
5.7.2 Deal Analysis 47
5.8 BMS and Vanderbilt University Sign Deal to Develop Drugs for Parkinson’s 49
5.8.1 Deal Summary 49
5.8.2 Deal Analysis 49
5.9 AstraZeneca and Broad Institute Partner to Advance Discovery of Antibacterial and Antiviral Agents 50
5.9.1 Deal Summary 50
5.9.2 Deal Analysis 50
5.10 Bayer HealthCare Opens New Lab Space – The CoLaborator – for Biotech Startups 51
5.10.1 Deal Summary 51
5.10.2 Deal Analysis 51
5.11 Novartis Enters into Licensing Agreement with Penn for CART-19 53
5.11.1 Deal Summary 53
5.11.2 Deal Analysis 53
5.12 Sanofi and BWH Agree to Develop Antibodies for Type 1 Diabetes 55
5.12.1 Deal Summary 55
5.12.2 Deal Analysis 55
5.13 AstraZeneca and Leading Academic Organizations Collaborate on Alzheimer’s Research 56
5.13.1 Deal Summary 56
5.13.2 Deal Analysis 56
5.14 Novo Nordisk Enters into R&D Agreement with JDRF for Type 1 Diabetes 57
5.14.1 Deal Summary 57
5.14.2 Deal Analysis 57
5.15 Large Pharmas Unite with the Genome Institute of Singapore to Combat Cancer in Asian Populations 58
5.15.1 Deal Summary 58
5.15.2 Deal Analysis 58
5.15.3 Tech Transfer in Action: National University Singapore Startup AyoxxA Biosystems 59
5.16 University of Washington and ‘Big Pharma’ Join Forces to Research Drug Transporters 60
5.16.1 Deal Summary 60
5.16.2 Deal Analysis 60
5.17 Pharma and the University of Dundee Create Consortium on Cell Signaling Research 61
5.17.1 Deal Summary 61
5.17.2 Deal Analysis 61
5.18 Novo Nordisk and Oxford Join to Identify Novel Biomarkers for Rheumatoid Arthritis 62
5.18.1 Deal Summary 62
5.18.2 Deal Analysis 62
5.19 Elan Corporation and University of Cambridge Enter into Joint Venture to Discover New Therapies Targeting Neurodegenerative Disorders 63
5.19.1 Deal Summary 63
5.19.2 Deal Analysis 63
5.20 GSK and Yale Partner to Develop New Drugs Targeting Disease-Causing Proteins 64
5.20.1 Deal Summary 64
5.20.2 Deal Analysis 64
5.21 Big Pharma Companies and Research Institutions Tackle Early-Stage Research TB 65
5.21.1 Deal Summary 65
5.21.2 Deal Analysis 65
5.22 Accuray Signs Collaboration Agreement with University of Heidelberg to Provide Cutting-edge Research in Radiation Oncology 66
5.22.1 Deal Summary 66
5.22.2 Deal Analysis 66
5.23 UCB and Oxford University Join to Focus on Developing Innovative Medicines for Immunological and Neurological Disorders 67
5.23.1 Deal Summary 67
5.23.2 Deal Analysis 67
5.24 Large Pharma and King’s College London Establish a Center to Tackle Autism 69
5.24.1 Deal Summary 69
5.24.2 Deal Analysis 69
5.25 Merck Establishes an Independent Non-profit Drug Research Institute – the California Institute for Biomedical Research 70
5.25.1 Deal Summary 70
5.25.2 Deal Analysis 70
5.26 J&J and University of Queensland Develop Drugs Using Spider Venom for Treating Pain 71
5.26.1 Deal Summary 71
5.26.2 Deal Analysis 71
5.27 Sanofi and UCSF Form a Pact to Work on New Treatments for Diabetes 73
5.27.1 Deal Summary 73
5.27.2 Deal Analysis 73
5.27.3 Tech Transfer in Action: Tufts University Spin-off Anchor Therapeutics 74
6 Future Outlook 76
7 Appendix 77
7.1 Research Methodology 77
7.1.1 Coverage 77
7.1.2 Secondary Research 77
7.1.3 Expert Panel Validation 78
7.2 About the Author 78
7.2.1 Analyst 78
7.3 Director, Healthcare Industry Dynamics 79
7.4 Global Head of Healthcare 79
7.5 About the Industry Dynamics Team 79
7.6 GlobalData 80
7.7 Contact Us 80
7.8 Disclosure Information 80
7.9 Disclaimer 80
【レポート販売概要】
■ タイトル:PharmaSphere: Early-Stage Technology Transfer Collaborations – Enabling Platform Technologies & Deal Synergies between Academia and the Pharmaceutical Industry■ 英文:PharmaSphere: Early-Stage Technology Transfer Collaborations - Enabling Platform Technologies & Deal Synergies between Academia and the Pharmaceutical Industry
■ 発行日:2013年4月30日
■ 調査会社:GlobalData
■ 商品コード:GDATA403160902
■ 調査対象地域:グローバル
- SandRidge Energy, Inc.:石油・ガスの開発・生産動向及びコスト分析- Q2, 2013SandRidge Energy, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q2, 2013 Summary SandRidge Energy, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential sour …
- 産業用冷凍の世界市場:提供品別(産業用冷却装置&構成要素)、構成要素別(コンプレッサー、コンデンサー、エバポレーター、コントロール、その他)、冷媒種類別(アンモニア、二酸化炭素、ハイドロフルオロカーボン(HFC)、その他)、用途別(フレッシュフルーツ&野菜、肉、家禽、魚、乳製品、アイスクリーム、飲料、化学薬品、医薬品、その他)、種類別(定置式冷凍&輸送用冷凍)The global industrial refrigeration market is expected to reach $29,133 million in 2026, from $19,666 million in 2018, growing at a CAGR of 4.9% from 2019 to 2026. Industrial refrigeration refers to the process of cooling using refrigeration and cooling systems to remove the heat from a low-temperature medium and transferring it to a high-temperature medium. Industrial refrigeration systems are de …
- 船舶用電源装置の世界市場About Marine Power Systems The marine auxiliary engine is used to generate electricity onboard marine vessels, which is termed as an auxiliary unit. Initially, steam turbine propulsion was used, which was later replaced by diesel, LNG, nuclear, and other fuels. Nuclear propulsion is used for naval purposes for its fast movement, and the other type of fuel ships are used for the commercial purposes …
- 世界のシェールガス産業における主要企業分析The extraction of oil and gas from shale formations is a relatively new phenomenon with commercial production only first occurring in the twenty-first century. Shale rock formations have low permeability and porosity and so require the use of horizontal drilling and hydraulic fracturing in order to extract the hydrocarbon resources. The techniques to develop hydrocarbons from shale formations was …
- 半導体ウェーハ洗浄装置の世界市場2015-2019About semiconductor wafer cleaning systems Electronic devices are made up of different components, which are made up of semiconductor wafers. The quality of the device is dependent upon the quality of the semiconductor wafers, which undergoes many processes during the production process. Each process can contaminate the wafer by imposing some impurities on the wafer surface. As these wafers are sm …
- 免疫療法用治療薬の世界市場:単クローン抗体、インターフェロンα、インターロイキン、ワクチン、チェックポイント阻害薬The immunotherapy drugs market is expected to grow at a CAGR of 12.8% to reach USD 73,529.2 Million by 2020. The growing focus on cancer therapies with fewer side effects is a key factor driving the growth of the global immunotherapy drugs market. Other factors driving the market include high prevalence rate of lifestyle diseases including cancer, fast track and orphan drug designations expediting …
- 3D及び4D技術の世界市場(2013 – 2020)The 3D and 4D technologies are now widespread across a range of display, imaging, and entertainment platforms. These provide users with a whole new level of experience, immersion, interaction, and realism and, thus, the 3D and 4D technologies have become a mainstream element of cinema, television, internet, video games, and mobile phones. A major breakthrough in terms of developing these technolog …
- グローバル電子請求(e-Invoicing)市場動向(2014-2018)About e-invoicing E-invoicing is the exchange of bills and related invoice documents between enterprises and their clients in an integrated electronic format, usually using the internet. Also known as e-billing, e-invoicing is a part of electronic data interchange transactions that include data from the enterprise in a format that can be integrated into the client's financial system without the in …
- RTLS(リアルタイム位置情報システム)ソリューションの世界市場About Global Real-time Location System (RTLS) An RTLS is a technology that is used to find, track, manage, and identify the geographical position of a target on a real-time basis. It can track the location of objects in real time with the help of nodes or tags and readers. Nodes or tags are embedded in smartphones or navigational devices. A reader is used to receive wireless signals from the tags …
- インタラクティブ・テーブルの世界市場2016-2020About the Interactive Tables Market Interactive tables are also known as multi-touch tables. They are used to deliver collaborative learning in the education sector. Since the emergence of BYOD policies and the advent of touch screen devices in the education market, the practice of direct group interaction with a given subject matter at the touch of a finger is becoming more rampant. The younger g …
- 世界のクロマトグラフィー樹脂市場:種類別(天然、合成、無機メディア)、技術別(イオン交換、親和性、疎水性相互作用、サイズ排除、マルチモーダル)、用途別(医薬品&バイオテクノロジー、食品&飲料)、地域別“Growing demand for therapeutic antibodies and increasing biopharmaceutical R&D activities are expected to drive the chromatography resin market.” The global chromatography resin market size is projected to grow from USD 2.1 billion in 2019 to USD 3.0 billion by 2024, at a CAGR of 7.2%. The market is largely driven by the increasing demand for therapeutic antibodies. Chromatography is an essential …
- 企業用WLANの世界市場予測(~2021)The global enterprise Wireless Local Area Network (WLAN) market is expected to grow from USD 5.53 Billion in 2016 to USD 21.10 Billion by 2021, at a Compound Annual Growth Rate (CAGR) of 30.7%. The rapidly growing market for enterprise WLAN technology is expected to influence the cloud technology as well as Internet of Things (IoT) market, and thereby considerably increase market competitiveness. …
- 熱伝導性材料の世界市場:ポリマー材料、フェイズチェンジ材、金属材料About TIM TIM is used to support heat sinks in removing heat from heat sources in various equipment. It is generally used in the form of a secondary thermally conducting material to replace the thermally insulating air between the two surfaces. Along with helping in the efficient transfer of heat, TIM also acts as an adhesive and strengthens the mechanical link between the surfaces. Polymer-based …
- セラミック系接着剤の世界市場2019-2023About this market Ceramic adhesives are widely used in the construction industry for the installation of tiles and flooring, roofing, and wall coverings. Ceramic adhesives are mostly used to bind ceramic products in tile flooring, stone floor pasting, and polyethylene floor pasting applications. Emerging economies are witnessing an increasing demand for ceramic adhesives due to ongoing infrastruct …
- 睡眠ポリグラフ装置の世界市場2019-2023Global Polysomnography Devices Market: About this market Technavio’s polysomnography devices market analysis considers sales from hospitals, sleep clinics and diagnostic laboratories, ASCs, and homecare. Our analysis also considers the sales of polysomnography devices in Asia, Europe, North America, and ROW. In 2018, the hospitals' segment had a significant market share, and this trend is expected …